Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:38:41.086Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:38:41.086Z.
Quote observation: 2026-10-06T16:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f8447282adf6e47d1ec21ed7020f0f216562717f012d53baf90ed137265b4b00
FORWARD PE RATIO
N/A
Profusa, Inc. Common Stock
Market Cap
$1.81M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.81M | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.82M | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.94M | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | N/A |
| Curis, Inc. (CRIS)vs › | $1.49M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.49M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.21M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
